What is XOMA's P/E ratio?

Xoma Royalty Corporation (XOMA) currently trades at a P/E ratio of 22.54.

Xoma Royalty Corporation reports a Return on Equity (ROE) of 27.91%.

What is XOMA's dividend yield?

Xoma Royalty Corporation offers a dividend yield of 0.00%.

What is XOMA's Quality Score?

Our AI rates XOMA's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy XOMA?

Our AI Timing Score for XOMA is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does XOMA belong to?

Xoma Royalty Corporation is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Xoma Royalty Corporation (XOMA) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-13 | FS: 2026-03-31)

XOMA AI Analysis Summary

Our AI summary for XOMA: Xoma Royalty Corporation (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 22.54, ROE of 27.91%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

XOMA

Xoma Royalty Corporation

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 40.17

-4.05 (-9.16%) Day Change

Watchlist Portfolio Compare Chart

22.54

P/E

0.93

D/E

27.9%

ROE

11.6%

ROA

0.00%

Div Yield

-0.38

PEG

XOMA ROYALTY CORPORATION
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 40.17 Price -4.05 (-9.16%) Day Change	NEWS SCORE: 91

XOMA, the overall quality is not quite good ( Quality = 54) but the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	886
Magic Formula Rank by ROE	886
Magic Formula Rank by ROIC	913
Price	40.17
PBV / Sector	6.29 / 44,022.72
Earning Per Share	1.78

PE / Sector	22.54 / 19.17
PEG or PE/Growth / Sector	-0.38 / 1.24
Average 1M Daily Value	15.54 M GREAT
Average 1W Daily Value	42.31 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	86.97 / 98.24 GREAT
NPM Average (%) / Sector	-208.54 / -1,697.63
NPM Change Average (%) / Sector	-18.57 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	11.59 / 185,260.96
ROA Average (%) / Sector	-2.53 / 36,684.70
ROA Change Average (%) / Sector	-76.91 / 422,221.66
ROE (%) / Sector	27.91 / 243,762.23 GOOD
ROE Average (%) / Sector	-3.65 / 48,758.47
ROE Change Average (%) / Sector	-29.74 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:01:06
Symbol	XOMA
Name	XOMA ROYALTY CORPORATION
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	17.68 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	710.16 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2200 Powell Street, EmeryVille, CA, United States, 94608

Phone: 510 204 7200

Website: https://www.xoma.com

Sector: Healthcare >> Biotechnology

Description: XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. As of July 14, 2026, XOMA Royalty Corporation operates as a subsidiary of Ligand Pharmaceuticals Incorporated.